Bone Marrow Cells Inhibit BMP-2-Induced Osteoblast Activity in the Marrow Environment
- 23 October 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 34 (2) , 327-332
Abstract
Bone morphogenetic protein 2 (BMP‐2) is widely known as a potent growth factor that promotes bone formation. However, an increasing number of studies have demonstrated side effects of BMP‐2 therapy. A deeper understanding of the effect of BMP‐2 on cells other than those involved directly in bone remodeling is of fundamental importance to promote a more effective delivery of BMP‐2 to patients. In this study, we aimed to investigate the effect of BMP‐2 in the marrow environment. First, BMP‐2 adsorbed onto titanium implants was delivered at the tooth extraction socket (marrow‐absent site) or in the mandible marrow of beagle dogs. BMP‐2 could induce marked bone formation around the implant at the tooth extraction socket. Surprisingly, however, no bone formation was observed in the BMP‐2‐coated titanium implants inserted in the mandible marrow. In C57BL/6 mice, BMP‐2 adsorbed in freeze‐dried collagen pellets could induce bone formation in marrow‐absent calvarial bone. However, similar to the canine model, BMP‐2 could not induce bone formation in the femur marrow. Analysis of osteoblast differentiation using Col1a1(2.3)‐GFP transgenic mice revealed a scarce number of osteoblasts in BMP‐2‐treated femurs, whereas in the control group, osteoblasts were abundant. Ablation of femur marrow recovered the BMP‐2 ability to induce bone formation. In vitro experiments analyzing luciferase activity of C2C12 cells with the BMP‐responsive element and alkaline phosphatase activity of MC3T3‐E1 osteoblasts further revealed that bone marrow cells inhibit the BMP‐2 effect on osteoblasts by direct cell–cell contact. Collectively, these results showed that the effect of BMP‐2 in inducing bone formation is remarkably repressed by marrow cells via direct cell–cell contact with osteoblasts; this opens new perspectives on the clarification of the side‐effects associated with BMP‐2 application. © 2018 American Society for Bone and Mineral Research.Keywords
Funding Information
- Okayama Dental School and JSPS KAKENHI (JP16H0552418)
This publication has 20 references indexed in Scilit:
- A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2Tissue Engineering Part B: Reviews, 2016
- BMP2 induces chondrogenic differentiation, osteogenic differentiation and endochondral ossification in stem cellsCell and tissue research, 2016
- High Doses of Bone Morphogenetic Protein 2 Induce Structurally Abnormal Bone and Inflammation In VivoTissue Engineering Part A, 2011
- Regulation of osteoblast differentiation mediated by BMP, Notch, and CCN3/NOVJapanese Dental Science Review, 2008
- Interbody fusion with allograft and rhBMP-2 leads to consistent fusion but early subsidenceThe Journal of Bone and Joint Surgery. British volume, 2007
- Resorptive Response of rhBMP2 Simulating Infection in an Anterior Lumbar Interbody Fusion With a Femoral RingJournal of Spinal Disorders & Techniques, 2006
- Bone Morphogenetic Protein-2-induced Alkaline Phosphatase Expression Is Stimulated by Dlx5 and Repressed by Msx2Journal of Biological Chemistry, 2004
- Effect of recombinant human bone morphogenetic protein-2 on the osseointegration of dental implants: a biomechanics studyClinical Oral Investigations, 2004
- BMP2 initiates chondrogenic lineage development of adult human mesenchymal stem cells in high-density cultureDifferentiation, 2003
- BMP treatment of C3H10T1/2 mesenchymal stem cells induces both chondrogenesis and osteogenesisJournal of Cellular Biochemistry, 2003